Letters, Testimony & Comments

August 25, 2004
Expressing concern regarding the permitting system for the importation and possession of transgenic aquatic animals (August 25, 2004).
August 23, 2004
Docket No. 2004S-0233, Federal Register: May 24, 2004.
August 20, 2004
August 20th, 2004 Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, Maryland 20852 Re: Docket No. 2004N-0194, Federal Register: May 7, 2004 (Volume 69, Number 89, Page 25527-25533) Dear Sir/...
August 10, 2004
Joint letter with Plasma Protein Therapeutics Association (PPTA) concerning intravenous immune globulin ("IVIG")
August 2, 2004
Docket No. 2004-N-0181, 69 Federal Register, 21839 (April 22, 2004)].
July 26, 2004
Letter to Herb Kuhn, Director, Center for Medicare Management at the Centers for Medicare and Medicaid Services
July 24, 2004
Background: On February 3, 2003, President Bush unveiled the details of Project BioShield, a comprehensive effort by the federal government to stimulate drug and vaccine development, to protect American citizens against attacks by biological or...
July 14, 2004
TESTIMONY OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION BEFORE THE JUDICIARY COMMITTEE OF THE UNITED STATES SENATE IMPORTATION OF PRESCRIPTION DRUGS JULY 14, 2004 The Biotechnology Industry Organization (BIO) appreciates the opportunity...
July 2, 2004
Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment.
July 2, 2004
Development and Use of Risk Minimization Action Plans.
July 2, 2004
Premarketing Risk Assessment.
July 1, 2004
In response to §1013 of the Medicare Prescription Drug, Improvement, and Modernization Act.
June 24, 2004
at the Global Public Policy Institute and Ecole de Science Politique
June 7, 2004
Dear Majority Leader Frist: We, the undersigned biotechnology executives, strongly oppose further efforts to legalize prescription drug importation. Importation will put patients at risk, chill investment in biotechnology and other...
June 1, 2004
Re: Docket No. 2004N-0115 Request for Comment on Prescription Drug Importation Dear Dr. Carmona and Members of the HHS Task Force on Importation: The Biotechnology Industry Organization (BIO) submits the following comments in response to the...
May 26, 2004
On behalf of the Biotechnology Industry Organization (BIO), please accept this letter in support of Senate Bill 74, a bill that would prohibit reproductive human cloning in Louisiana. We understand the Committee on Health & Welfare will...